Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affymax IncfiledCriticalAffymax Inc
Priority to MYPI20044684priorityCriticalpatent/MY140065A/en
Publication of MY140065ApublicationCriticalpatent/MY140065A/en
THE PRESENT INVENTION RELATES TO PEPTIDE COMPOUNDS THAT ARE AGONISTS OF THE ERYTHROPOIETIN RECEPTOR (EPO-R). THE INVENTION ALSO RELATES TO THERAPEUTIC METHODS USING SUCH PEPTIDE COMPOUNDS TO TREATS DISORDERS ASSOCIATED WITH INSUFFICIENT OR DEFECTIVE RED BLOOD CELL PRODUCTION. PHARMACEUTICAL COMPOSITIONS, WHICH COMPRISE THE PEPTIDE COMPOUNDS OF THE INVENTION, ARE ALSO PROVIDED.
MYPI200446842004-11-102004-11-10Novel peptides that bind to the erythropoietin receptor
MY140065A
(en)
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling